guys breathe easy... Spoke to the company regarding the Aridol Phase 3 results. Here are some of the key points to make holders feel a little more comfortable about the results
- Although the specificity and sensitivity results from the US phase 3 trial are similar it is probable that further analysis of the data will reveal significant differences. In addition the US study was confined to a very specific niche of patients (patients with suspected asthma/ no certain diagnosis). Aridol has applications in a far wider group of patients than this, so one shouldn’t extrapolate the results of this study too far.
- Aridol is an indirect challenge test and measures a patient’s inflammatory response to an osmotic stimulus. This is very different to a direct challenge test like methacholine which acts directly on the airway smooth muscle.
- Aridol positive patients have active airway inflammation and are therefore likely to respond to inhaled steroids. The same cannot be said of methacholine.
- Aridol is thus a more clinically useful test.
- Aridol offers a standard operating procedure for challenge testing removing the many variables that can effect methacholine testing.
- Aridol is a faster and cleaner test that both patients and operators will prefer.
- Aridol has further potential applications in monitoring patient’s response to treatment and managing asthma.
- Forums
- ASX - By Stock
- time for news
guys breathe easy... Spoke to the company regarding the Aridol...
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
2.5¢ |
Change
-0.001(3.85%) |
Mkt cap ! $29.85M |
Open | High | Low | Value | Volume |
2.5¢ | 2.6¢ | 2.3¢ | $43.43K | 1.812M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 214728 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.5¢ | 52432 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 151728 | 0.022 |
5 | 793867 | 0.021 |
13 | 3917674 | 0.020 |
3 | 1026988 | 0.019 |
3 | 1002999 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.025 | 20000 | 1 |
0.027 | 250000 | 2 |
0.029 | 347870 | 2 |
0.030 | 358058 | 3 |
0.031 | 687842 | 2 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online